RecruitingNot ApplicableNCT06876350

Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Patient Satisfaction for Post-Operative Carpometacarpal Arthroplasty: Wood Casting Versus Thermoplastic Splint


Sponsor

Foundation for Orthopaedic Research and Education

Enrollment

26 participants

Start Date

Oct 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares two types of post-surgical splints — a traditional thermoplast splint and an eco-friendly woodcast splint — to see which patients prefer after carpometacarpal (CMC) joint arthroplasty, a thumb joint reconstruction surgery. Patient preference, comfort, and compliance with wearing the splint are the main outcomes being measured. Adults 18 and older who are eligible for CMC arthroplasty, have intact decision-making ability, and are willing to attend follow-up visits over 6 weeks may participate, while pregnant women and those deemed unsuitable by the investigator are excluded. Participation involves receiving the assigned splint after surgery and completing surveys about your experience over 6 weeks. This summary was generated with AI assistance to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERWoodcasting Splint

This is the experimental group so we could see the outcomes and preference for patients using surveys and compliance scores

OTHERControl (Standard treatment)

Thermoplastic splints are standard of care treatment for patients after CMC arthroplasty. We will use the data from this group as the comparator to the experimental group.


Locations(1)

Florida Orthopaedic Institute

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06876350